Highly attenuated vaccinia virus DIs as a potential SARS vaccine

Adv Exp Med Biol. 2006:581:593-6. doi: 10.1007/978-0-387-33012-9_107.

Authors

Koji Ishii¹, Hideki Hasegawa, Noriyo Nagata, Tetsuya Mizutani, Shigeru Morikawa, Masato Tashiro, Tetsuro Suzuki, Fumihiro Taguchi, Toshitada Takemori, Tatsuo Miyamura, Yasuko Tsunetsugu-Yokota

Affiliation

¹ National Institute of Infectious Diseases, Tokyo, Japan.

No abstract available

MeSH terms

Animals
Antibodies, Viral / chemistry
Humans
Immunoglobulin G / chemistry
Mice
Mice, Inbred BALB C
Recombinant Proteins / chemistry
Severe Acute Respiratory Syndrome / genetics*
Severe Acute Respiratory Syndrome / prevention & control*
Severe acute respiratory syndrome-related coronavirus / genetics*
Vaccinia virus / metabolism*
Viral Envelope Proteins
Viral Vaccines / pharmacology*

Substances

Antibodies, Viral
Immunoglobulin G
Recombinant Proteins
Viral Envelope Proteins
Viral Vaccines